How have the shares performed?
Portage Biotech Inc. (PRTG) saw downtrend of -25.43% in the recent trading with $25.95 being its most recent. The current price level -42.30% lower than the highest price of $44.98 marked by the stock while trading over the past 52-weeks, whereas it is 200.00% higher than the lowest price of $8.65 the company dropped to over past 52-weeks. The latest news story on PRTG appeared in Newsfile under the title “Portage Biotech Inc. Announces Pricing of Public Offering of 1,000,000 Ordinary Shares” on Jun-24-21.
Squeezing the time span to 30 day period shows us the stock is currently trading -42.30% below one month high and is +4.93% above of the lowest during that time. Looking into the simple moving average, Portage Biotech Inc. (PRTG)’s stock stands at a SMA-50 of $30.15 while that of 5-day is reading $34.85.
Daily rise and fall of price influence many of the traders, and in order to overcome the fluctuating effect of that and to watch the stock closely, traders focus more on stock’s 200-day moving average. At various points in trading activity, investors are more likely to be making use of that measure as a strong indicator in figuring out their support and resistance levels, and PRTG’s SMA-200 as of now is $21.66.
Portage Biotech Inc. Earnings – What Happened With PRTG
Coming around sales and income figures, publically trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
PRTG – Portage Biotech Inc. Stock Earnings Estimates
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 12.03 million. PRTG does have institutional investors; and they hold 0.30% of the stock.
Portage Biotech Inc. – Insider Activity and Holdings
As on Mar 30, 2021, Beacon Investment Advisory Services, Inc. was the top most holder in Portage Biotech Inc. (NASDAQ:PRTG) with an ownership of 11395.0 shares of the company or 0.10% of the stake worth $0.32 million. The filing also reveals Sigma Planning Corp as the second largest holder in the company with a control over 0.08% of the outstanding shares. Its stake is worth $0.26 million for having 9270.0 shares in hand.
Morgan Stanley also came holding a key position in the company during the recent quarter and it now holds 0.07% of the outstanding shares. With this there are now 8 institutions which have possession in PRTG’s shares.
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, current ratio recorded by Portage Biotech Inc. was 1.48 while posting a debt to equity ratio of 0.00. The count was 3.48 for long-term debt to equity ratio.
Portage Biotech Inc.’s return on equity, or ROE, is -5.50%, compared to the industry average of -40.21% for Healthcare – Biotechnology. Although this indicates that PRTG uses its equity well, the metric will vary significantly depending on the industry.
Technical Analysis of Portage Biotech Inc. (NASDAQ:PRTG) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Portage Biotech Inc. (PRTG), we notice that the stock’s 20-day average volume is at 87,510 shares and 50% of short term indicators are suggesting the stock as Buy. Its 50-day average volume of 43,240 shares. And to end, PRTG’s 100-day average volume is 27,361 shares with 50% of the long-term indicators pointing towards Buy for the stock.